drugset / Trial / NCT01155388
A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease
RandomizedParallel-groupOpen-labelTreatment
Summary
Study evaluating the efficacy and safety of intravenous (IV) ferumoxytol compared with oral iron for the treatment of pediatric participants with chronic kidney disease (CKD).
Timeline
- Start
- 2011-10-17
- Primary completion
- 2014-06-24
- Completion
- 2014-06-24
Outcome
Outcome not reported
Stopped (Enrollment): “Several factors contributed to significant challenges in enrollment and led the Sponsor to discontinue the AMAG-FER-CKD-252 study as designed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxytol | Diagnostic / imaging agent | 3.5 mg/kg | Intravenous |
| Subject | Ferumoxytol | Diagnostic / imaging agent | 7 mg/kg | Intravenous |
| Comparator | Oral Iron | Unknown | 2.5 mg/kg | Oral |